我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

长期应用阿托伐他汀对冠心病患者颈动脉粥样斑块的影响(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2007年第3期
页码:
311-314
栏目:
临床研究
出版日期:
2007-06-01

文章信息/Info

Title:
Effect of longterm administration of Atorvastatin on carotid atherosclerosis in patients with coronary heart disease
作者:
殷忠1; 刘丽文2 ; 李兰荪1 ; 钱蕴秋2 ; 谢学建1 ; 王海昌1
第四军医大学西京医院：1.心内科，2.超声诊断科，陕西 西安 710032
Author(s):
YIN Zhong1;  LIU Liwen2;  LI Lansun1;  QIAN Yunqiu2;  XIE Xuejian1;  WANG Haichang1
1.Department of Cardiology, 2.Department of Ultrasound Diagnostics, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, Shaanxi, China
关键词:
多普勒超声; 彩色; 颈动脉粥样硬化斑块; 内中膜厚度; 阿托伐他汀　
Keywords:
Doppler ultrasonography; color;  carotid artery atherosclerosis plaque;  　intimamedia thickness;  atorvastatin
分类号:
R541.4；R972.6
DOI:
-
文献标识码:
A
摘要:
目的 观察长期应用阿托伐他汀对冠心病患者颈动脉粥样硬化斑块的影响。方法 经冠脉造影证实为冠心病并经超声检查颈动脉有不同程度斑块者44（男28，女16）例，年龄（61 ±10）岁，给予阿托伐他汀10 mg，口服，每晚1次，共2年。每6个月检测1次患者血脂水平，同时用彩色多普勒超声观察患者颈动脉系统内径、内中膜厚度、斑块大小的变化。结果 ①治疗6 个月后，阿托伐他汀可以使TC、LDLC水平降低，与治疗前比较有显著性差异( P<0.01)；随治疗时间延长，TG水平逐渐降低；HDLC水平渐升高，但直至治疗18月及24月，才与治疗前有显著性差异。②与治疗前相比，颈动脉内径有所扩大，内中膜厚度减小，颈动脉斑块缩小。结论 阿托伐他汀降脂疗效确切，并有扩大血管内径，减小内中膜厚度的作用。长期服用阿托伐他汀对冠心病患者的颈动脉粥样硬化斑块有消退作用。
Abstract:
AIM To observe the effect of longterm administration of Atorvastatin on carotid artery atherosclerosis in patients with coronary heart disease (CHD). METHODS Fortyfour patients with CHD and different degrees of carotid plaques detected by coronary artery angiography and ultrasonography ［n=44, M 28, F 16, mean age: (61±10) years］ received Atorvastatin 10 mg, po, qn for 2 years. The effects of Atorvastatin on the patients' lipid parameters including TC, TG, LDLC and HDLC were observed and the changes of artery diameter, intimamedia thickness (IMT) and artery plaque were observed by carotid color Doppler ultrasonography. RESULTS ① 6 months after treatment with Atorvastatin, TC and LDLC decreased, with significant differences before and after treatment (P<0.01). The level of HDLC increased and TG decreased but there was no significant difference until 18 or 24 months. ②After treatment, carotid diameter increased, intimamedia thickness was thinner, and the thickness of plaque decreased. CONCLUSION Longterm administration of Atorvastatin has some therapeutic effect and Atorvastatin enlarges the internal diameter of carotid artery and decreases the IMT. Longterm administration of Atorvastatin is effective in the treatment of carotid artery atherosclerosis in CHD patients.

参考文献/References

［1］ Malinow MR, Nieto FJ. Carotid artery intimalmedial wall thickening and plasma homocystine in asymptomatic adults［J］.Circulation, 1993，87（4）: 1107-1113.

［2］ 沈敏,李兰荪,贾国良,等.超声检测颈动脉粥样硬化及其与冠心病的相关性分析［J］.第四军医大学学报，2003，24(6):532-535.

［3］ Raitakari OT , Adams MR , Celermajer DS. Effect of lipoprotein(a)on the early functional and structural changes of atherosclerosis［J］. Arterioscler Thromb Vasc Biol，1999 , 19（4）: 990 - 995.

［4］ Held C, Hjemdahl P, Eriksson SV, et al.Prognostic implication of intimamedia thickness and plaques in the carotid and femoral arteries in patients with stable angina pectoris［J］. Eur Heart J，2001，22（1）:62-72.

［5］ Bucciarelli P, Sramek A, Reiber JH, et al. Arterial intimamedia thickness and its relationship with cardiovascular disease and atherosclerosis: a possible contribution of mediumsized arteries［J］. Thromb Haemost，2002，88（6）: 961-966.

［6］ 程纯,吴士尧. 普伐他汀对冠心病患者颈动脉粥样斑块的影响［J］. 中国临床药学杂志,2001 ,10(3) :140-143.

［7］ O'Leary DH，Polak JF, Kponmal RA. Carotid artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults［J］ . N Engl J Med ,1999 ,340（1）∶14-22.

［8］ Harsch M , Bracsen JH, Niendarf A. Effects of lowdose pravastatin sodium on plasma cho lesterol levels and aortisatherosclerosis of heterozygons WHHL rabbits fed a low cholesterol ( 0.03% ) enriched diet for one year［J］. Atherosclerosis, 1997, 128 (2) : 139-147.

［9］ Nissen SE , Tuzcu EM, Schoenhagen P , et al. Effect of intensive compared with moderate lipidlowering therapy on progression of coronary atherosclerosis［J］ . JAMA ，2004 ,291(9) :1071-1080.

［10］Schwartz GG，Olsson AG，Ezekowitz MD，et al. Effect of atorvastatin on early recurrent ischemic events in acute coronary syndromes：the MIRACLE study:a randomized controlled trial［J］ . JAMA,2001,285(13):1711-1718.

备注/Memo

备注/Memo:
收稿日期：2006-05-30.通讯作者：李兰荪，教授，主任医师，主要从事冠心病的诊断及治疗研究Lilansun@sina.com 作者简介：殷忠，硕士Email： ouandyin1219@163.com
更新日期/Last Update: